BiotechTube
Home/NeuCen Biomedical/Tung Ling Li
TL

Tung Ling Li

Founder & CEO

NeuCen Biomedical

Therapeutic Areas

AllergyOncology

NeuCen Biomedical Pipeline

DrugIndicationPhase
CEN501Allergic RhinitisPreclinical
NEU001Nasopharyngeal CarcinomaPhase 1